KP Tissue Inc (TSE:KPT) was upgraded by Royal Bank Of Canada from a “sector perform” rating to an “outperform” rating in a report issued on Monday, StockTargetPrices.com reports. The firm presently has a C$17.00 price objective on the stock, up from their previous price objective of C$15.00. Royal Bank Of Canada’s price target would suggest a potential upside of 17.16% from the stock’s previous close.
A number of other equities analysts have also recently weighed in on the stock. Scotiabank reissued an “outperform” rating and issued a C$16.50 price objective on shares of KP Tissue in a research report on Thursday. TD Securities reissued a “hold” rating and issued a C$16.00 price objective on shares of KP Tissue in a research report on Friday, November 4th. CIBC increased their price target on shares of KP Tissue from C$16.00 to C$18.00 in a research report on Friday, November 4th. Finally, Desjardins raised shares of KP Tissue from a “hold” rating to a “buy” rating and increased their price target for the stock from C$13.50 to C$15.00 in a research report on Thursday, August 11th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of C$16.08.
Shares of KP Tissue (TSE:KPT) traded up 1.59% during trading on Monday, reaching $14.74. The company had a trading volume of 7,721 shares. The stock’s market capitalization is $134.00 million. The stock has a 50 day moving average of $14.22 and a 200 day moving average of $13.39. KP Tissue has a 52-week low of $9.70 and a 52-week high of $14.84.
KP Tissue Company Profile